US80105N1054 - ADR
46.75 +0.15 (+0.32%)
After market: 46.75 0 (0%)
These stocks aren't popular on the market right now, but investors shouldn't let that scare them off.
Regeneron and Sanofi are partnered on Dupixent, a treatment for conditions tied to type 2 inflammation.
Sanofi's Phase 3 trial of Dupixent for COPD shows significant reduction in exacerbations, potentially making it the first approved biologic for the...
Is SANOFI-ADR (NASDAQ:SNY) a Good Fit for Dividend Investing?
Sanofi's ADR's rose 0.5% as reports suggest the company is considering separating its consumer health business, working with Rothschild & Co.
SANOFI-ADR (NASDAQ:SNY) is an undervalued gem with solid fundamentals.
The company is looking to take on Regeneron and Sanofi's Dupixent in skin diseases.
Now could be a great opportunity to buy low.
/PRNewswire/ -- Sanofi has announced the winners of its 2023 Health Equity Accelerator Awards, honoring 10 nonprofit organizations that exemplify the company's...
EQNX::TICKER_START (NASDAQ:LEXX),(NYSE:JNJ),(NYSE:SNY),(NASDAQ:AMGN),(NYSE:NVS) EQNX::TICKER_END
/PRNewswire/ -- GLP-1 agonists have become incredibly popular obesity drugs, reshaping the standard of care as people increasingly turn to the new class of...
SNY earnings call for the period ending September 30, 2023.
Sanofi (SNY) shares hit a new 52-week low amid a downwardly revised forecast and news that it intends to spin out its consumer products division. Read more here.
Microsoft, Google, Amazon and Meta led big earnings.
Stocks are up on Friday as investors react to a positive earnings report from Amazon that has other tech stocks moving in sympathy with AMZN.
Nikola stock is on the rise Friday as shares of NKLA continue a climb this week on positive news of $165 million award from a court case.
The happy talk in Sanofi's press release didn't help with analysts, who have been disappointed in the company and SNY stock all year.
The company announced plans to spin off its consumer health division.
It's time to start off the final trading day this week with a breakdown of the biggest pre-market stock movers on Friday!